Stock listing
SANN Stock Price, News, Filings & Events — Santhera Pharmaceuticals Holding Ag
Selected listing: SANN · SIX · CHF · CH
This page tracks Santhera Pharmaceuticals Holding Ag's SANN:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SANN:SIX. SANN:SIX is the stock-level entry point for investors researching Santhera Pharmaceuticals Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Santhera Pharmaceuticals Holding AG is a public company listed on the Swiss market under the ticker SANN. The company has a market capitalization of approximately 268 million Swiss francs. Santhera focuses on developing innovative therapies for rare diseases, particularly in the field of neuromuscular disorders.
- Ticker
- SANN:SIX
- Asset type
- Stock
- Market cap
- $306.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SIX
- Currency
- CHF
Santhera Pharmaceuticals Holding Ag SANN:SIX stock context
This page tracks Santhera Pharmaceuticals Holding Ag's SANN:SIX listing on SIX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SANN:SIX. SANN:SIX is the stock-level entry point for investors researching Santhera Pharmaceuticals Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Santhera Pharmaceuticals Holding AG is a public company listed on the Swiss market under the ticker SANN. The company has a market capitalization of approximately 268 million Swiss francs. Santhera focuses on developing innovative therapies for rare diseases, particularly in the field of neuromuscular disorders.
Latest news from Santhera Pharmaceuticals Holding Ag
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
July 13, 2026
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
June 2, 2026
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
April 30, 2026
Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
April 28, 2026
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
April 28, 2026
Santhera Pharmaceuticals Holding Ag earnings calls
Santhera Pharmaceuticals Holding AG (0QN1) Q4 2025 Earnings Call
April 28, 2026 · Replay with transcript and chapters
Santhera Pharmaceuticals Holding AG (0QN1) Q2 2025 Earnings Call
September 23, 2025 · Replay with transcript and chapters
Santhera Pharms Hldgs Ltd (SPHDF) Q4 2024 Earnings Call
September 12, 2024 · Replay with transcript and chapters
Research Santhera Pharmaceuticals Holding Ag
Santhera Pharmaceuticals Holding Ag investor report
Review AI stock analysis and investor report context for SANN:SIX.
Santhera Pharmaceuticals Holding Ag company profile
View the public company page for Santhera Pharmaceuticals Holding Ag on 6ix.
Santhera Pharmaceuticals Holding Ag news
Read company news and market updates connected to Santhera Pharmaceuticals Holding Ag.
Santhera Pharmaceuticals Holding Ag investor events
Find investor webinars, events, and replay context for Santhera Pharmaceuticals Holding Ag.
Alternate listings
SPHDF:OTC
US · USD
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
0QN1:LSE
GB · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:GETTEX
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
A3EJMQ:LSX
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
A3EJMQ:LS
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
SANNZ:AQUISUK
GB · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:BX
CH · CHF
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:TRADEGATE
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:DUS
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:FWB
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:HAM
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.
S3F0:MUN
DE · EUR
Alternate listing for Santhera Pharmaceuticals Holding Ag; the primary context on this page is SANN:SIX.